Board Meeting5 Aug 2026, 03:45 pm
Biogen Pharmachem Board Approves Un-audited Financial Results
AI Summary
Biogen Pharmachem Industries Ltd announced that its Board of Directors, in a meeting held on August 5, 2026, approved the un-audited financial results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee and have undergone a limited review by the statutory auditors. The company operates in a single segment. Previous period figures have been re-grouped where necessary.
Key Highlights
- Board meeting held on August 5, 2026.
- Approved un-audited financial results for Q1 FY27.
- Results reviewed by Audit Committee.
- Statutory Auditors conducted a limited review.
- Company has a single business segment.
Price Impact
More from BIOGEN